Jury Orders Express Scripts To Pay $82M In Sale Fraud Suit
Express Scripts Inc. will have to pay a Parthenon Capital Partners subsidiary $82.1 million after a Delaware jury found that Express had fraudulently inflated the price of a company specializing in biopharmaceutical clinical...To view the full article, register now.
Already a subscriber? Click here to view full article